Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Allergol Select ; 1(1): 21-27, 2017.
Article in English | MEDLINE | ID: mdl-30402598

ABSTRACT

Food allergens are frequent causes of anaphylaxis. In particular in children and adolescents they are the most frequent elicitors of severe allergic reactions, and in adults food allergens rank third behind insect venom and drugs. Since July 2006 severe allergic reactions from Germany, Austria, and Switzerland are collected in the anaphylaxis registry. Currently 78 hospitals and private practises are connected. From July 2006 until February 2009 1,156 severe allergic reactions were registered. Among children and adolescents (n = 187, age range from 3 months to 17 years) food allergens were the most frequent triggers, comprising 58% of cases. In the adult group (n = 968, 18 - 85 years) food allergens were in the third position (16.3%) behind insect venom and drugs. In children legumes (31%) and in particular peanuts were frequently responsible food allergens, followed by tree nuts (25%) with hazelnut being the most frequent elicitor. In adults fruits (13.4%) most often induced severe food-dependent anaphylaxis, but also animal products (12.2%); among these most frequently crustaceans and molluscs. Cofactors were often suspected in food-dependent anaphylaxis, namely in 39% of the adult group and in 14% of the pediatric group. In adults drugs (22%) and physical activity (10%) were reported to be the most frequent cofactors, in children physical activity was suspected in 8.7% and drugs in 2.6%. Concomitant diseases like atopic dermatitis, allergic asthma, or allergic rhinoconjunctivitis were reported in 78% of children and adolescents and in 67% of the adults. In conclusion, food-induced anaphylaxis, its cofactors and concomitant diseases are age-dependent. The data offers to identify risk factors of anaphylaxis.

2.
Hautarzt ; 60(6): 498-501, 2009 Jun.
Article in German | MEDLINE | ID: mdl-19387592

ABSTRACT

Ecthyma contagiosum (orf) is a dermatosis commonly seen in those in contact with sheep. It is caused by Parapoxvirus ovis (orf virus), an oval epitheliotropic DNA parapox virus. The skin disease develops in stages starting as a macule or papule, becoming nodular, and then regressing. Diagnosis is based on history and histology, as well as identifying the virus through cell culture or specified polymerase chain reaction (PCR). The treatment of this self-limited disease is usually symptomatic.


Subject(s)
Ecthyma, Contagious/complications , Ecthyma, Contagious/diagnosis , Forearm/pathology , Lymphangitis/diagnosis , Lymphangitis/etiology , Acute Disease , Adult , Diagnosis, Differential , Female , Humans , Papilloma/complications , Papilloma/diagnosis , Skin Neoplasms/complications , Skin Neoplasms/diagnosis
5.
Br J Dermatol ; 143(1): 127-31, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10886146

ABSTRACT

BACKGROUND: Erythrodermic cutaneous T-cell lymphomas (CTCL) including Sézary syndrome have been successfully treated with daily administration of chlorambucil and prednisone (Winkelmann regimen). OBJECTIVES: Our purpose was to determine the efficacy and safety of a low-dose pulse chemotherapy with chlorambucil and fluocortolone in this stage of the disease. Fluocortolone has the same potency as prednisone but lacks a mineralocorticoid effect. PATIENTS/METHODS: Thirteen patients with erythrodermic CTCL (stages III-IVb) were treated with chlorambucil and fluocortolone therapy (chlorambucil 10-12 mg day-1 for 3 days and fluocortolone, first day 75 mg, second day 50 mg and third day 25 mg) as primary therapy in an uncontrolled pilot study. Treatment was started with pulses every 2 weeks; subsequently, the intervals were prolonged according to the clinical status. Clinical outcome, side-effects and long-term survival were assessed. RESULTS: Seven patients achieved a complete remission and six had a partial response (improved significantly). The mean duration of remissions was 16.5 (median 12) months. The mean number of cycles necessary during the first year was one cycle every 5 weeks. No treatment-related severe side-effects occurred. The long-term follow-up (mean 31.5, median 27 months) showed that six patients remained in complete remission and three showed a stable partial remission. Four patients died, two of them from their lymphoma. CONCLUSIONS: We conclude that pulse chemotherapy with chlorambucil and fluocortolone is effective and safe in the treatment of erythrodermic CTCL and should be considered as an alternative to the classical Winkelmann treatment scheme.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antineoplastic Agents, Alkylating/therapeutic use , Chlorambucil/therapeutic use , Fluocortolone/therapeutic use , Glucocorticoids/therapeutic use , Lymphoma, T-Cell, Cutaneous/drug therapy , Skin Neoplasms/drug therapy , Aged , Disease-Free Survival , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Pilot Projects , Pulse Therapy, Drug
6.
Br J Dermatol ; 143(1): 154-6, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10886151

ABSTRACT

About 50% of cases of pyoderma gangrenosum (PG) are associated with a variety of systemic diseases. We describe a patient with severe PG on both legs who suffered from an autoimmune haemolytic anaemia in association with a congenital deficiency of complement factors C2 and C4. To the best of our knowledge, this constellation has not been previously reported.


Subject(s)
Anemia, Hemolytic, Autoimmune/complications , Complement C2/deficiency , Complement C4/deficiency , Pyoderma Gangrenosum/etiology , Adult , Anemia, Hemolytic, Autoimmune/drug therapy , Anemia, Hemolytic, Autoimmune/immunology , Anti-Inflammatory Agents/therapeutic use , Azathioprine/therapeutic use , Drug Therapy, Combination , Humans , Immunosuppressive Agents/therapeutic use , Male , Methylprednisolone/therapeutic use , Prednisone/therapeutic use , Pyoderma Gangrenosum/drug therapy
7.
J Invest Dermatol ; 113(2): 170-4, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10469299

ABSTRACT

There is a continuous need for methods to evaluate the biologic effects of topically applied drugs in the skin. Irritation of the epidermis with sodium dodecyl sulfate leads to an upregulation of E-selectin on endothelial cells and E-selectin mRNA can be detected in vivo within a short time. This study was aimed to investigate whether this biologic response can be used as a read-out for the anti-inflammatory effect of topically administered corticosteroids. We investigated skin of healthy volunteers treated according to the two following experimental protocols: (i) topical application of different corticosteroids (versus basic ointments as controls) for 12 h and irritation with sodium dodecyl sulfate 1% for 4 h; (ii) irritation with sodium dodecyl sulfate 1% for 12 h and application of the corticosteroids for 5 h. The biopsy specimens were subjected to RNA extraction and reverse transcription and competitive reverse transcriptase-polymerase chain reaction was performed using defined concentrations of a pre-constructed mimic DNA. As result, we found strong positive signals for wild-type E-selectin mRNA in all biopsies pretreated with basic ointments, whereas in biopsies from areas pretreated with corticosteroids the bands for wild-type E-selectin DNA could be detected at 10-1000 lower levels of mimic DNA concentrations. The reverse experiment, application of corticosteroids after the irritation, again yielded significantly reduced signals for E-selectin mRNA. In both experimental settings, the different strength of the topical corticosteroids used was reflected by significant differences in the amount of E-selectin mRNA found in the biopsies. This study demonstrates the pharmacologic effect of topical corticosteroids on the irritation-induced E-selectin mRNA expression on dermal endothelial cells in vivo using very small tissue samples and this approach may be of value for further pharmaceutical studies.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Dermatitis/genetics , E-Selectin/genetics , Prednisolone/analogs & derivatives , RNA, Messenger/metabolism , Administration, Topical , Adult , Biopsy , Drug Eruptions/etiology , Female , Humans , Hydrocortisone/therapeutic use , Male , Prednisolone/administration & dosage , Prednisolone/therapeutic use , Premedication , RNA, Messenger/drug effects , Skin/pathology , Sodium Dodecyl Sulfate/adverse effects , Triamcinolone/therapeutic use , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...